6-25653614-T-G
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_006998.4(SCGN):c.153+162T>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.282 in 152,056 control chromosomes in the GnomAD database, including 6,128 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.28 ( 6128 hom., cov: 32)
Consequence
SCGN
NM_006998.4 intron
NM_006998.4 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.109
Publications
4 publications found
Genes affected
SCGN (HGNC:16941): (secretagogin, EF-hand calcium binding protein) The encoded protein is a secreted calcium-binding protein which is found in the cytoplasm. It is related to calbindin D-28K and calretinin. This protein is thought to be involved in KCL-stimulated calcium flux and cell proliferation. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.54).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.327 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| SCGN | NM_006998.4 | c.153+162T>G | intron_variant | Intron 2 of 10 | ENST00000377961.3 | NP_008929.2 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| SCGN | ENST00000377961.3 | c.153+162T>G | intron_variant | Intron 2 of 10 | 1 | NM_006998.4 | ENSP00000367197.2 | |||
| ENSG00000290217 | ENST00000703602.1 | c.153+162T>G | intron_variant | Intron 2 of 11 | ENSP00000515390.1 | |||||
| SCGN | ENST00000612225.4 | n.82+1129T>G | intron_variant | Intron 1 of 9 | 5 | ENSP00000484392.1 |
Frequencies
GnomAD3 genomes AF: 0.282 AC: 42881AN: 151936Hom.: 6114 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
42881
AN:
151936
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.282 AC: 42923AN: 152056Hom.: 6128 Cov.: 32 AF XY: 0.278 AC XY: 20632AN XY: 74330 show subpopulations
GnomAD4 genome
AF:
AC:
42923
AN:
152056
Hom.:
Cov.:
32
AF XY:
AC XY:
20632
AN XY:
74330
show subpopulations
African (AFR)
AF:
AC:
13756
AN:
41444
American (AMR)
AF:
AC:
4202
AN:
15274
Ashkenazi Jewish (ASJ)
AF:
AC:
753
AN:
3466
East Asian (EAS)
AF:
AC:
1266
AN:
5174
South Asian (SAS)
AF:
AC:
1312
AN:
4814
European-Finnish (FIN)
AF:
AC:
2169
AN:
10588
Middle Eastern (MID)
AF:
AC:
80
AN:
294
European-Non Finnish (NFE)
AF:
AC:
18684
AN:
67978
Other (OTH)
AF:
AC:
580
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1578
3155
4733
6310
7888
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
442
884
1326
1768
2210
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1153
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.